Physician

Michael Colin Ryan, M.D.

According to 2025 Medicare claims, Michael Ryan, M.D. (NPI: 1639566003) practices ophthalmology in the Rochester, NY market, with the plurality of this provider's patient population coming from Monroe, NY. This provider's primary affiliated billing organization is EYE PHYSICIANS AND SURGEONS OF WESTERN NEW YORK PLLC (NPI: 1518032333) and primary practice location at 14580-2907. Ryan is affiliated with the NewYork Quality Care (ACO ID: A2571) and Rochester Regional Health ACO, Inc. (ACO ID: A3476), participating under the MSSP model.

Ryan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 223 traditional Medicare patients, billed 1,889 HCPCS/CPT codes, and received $266,687 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 619 prescription claims across 181 beneficiaries totaling $40,799 in drug costs, led by Rhopressa (Netarsudil Mesylate). Open Payments data shows 1 records totaling $110. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have risen steadily, from $3,629 to $40,799. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$151K$302K2021 Medicare payment: $58,089 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $301,605 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $285,947 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $266,687 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
202182426$58,089
20221692,312$301,605
20231842,122$285,947
20242231,889$266,687

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$20K$41K2015 Drug cost: $3,629 (USD; Tot_Drug_Cst)2016 Drug cost: $11,605 (USD; Tot_Drug_Cst)2017 Drug cost: $3,614 (USD; Tot_Drug_Cst)2018 Drug cost: $3,971 (USD; Tot_Drug_Cst)2019 Drug cost: $11,243 (USD; Tot_Drug_Cst)2020 Drug cost: $4,764 (USD; Tot_Drug_Cst)2021 Drug cost: $27,485 (USD; Tot_Drug_Cst)2022 Drug cost: $33,140 (USD; Tot_Drug_Cst)2023 Drug cost: $31,578 (USD; Tot_Drug_Cst)2024 Drug cost: $40,799 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/R35$3,629
20161771$11,605
20171890$3,614
20182181$3,971
201932121$11,243
20202950$4,764
202179224$27,485
2022149512$33,140
2023168586$31,578
2024181619$40,799

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye67277$89
92014Established patient complete exam of visual system92283$88
92012Established patient problem focused exam of visual system149251$58
J9035Injection, bevacizumab, 10 mg50195$57
92134Imaging of retina171459$28

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RhopressaNetarsudil Mesylate18794$6,129
Prednisolone AcetatePrednisolone Acetate1234,468$4,679
Brimonidine TartrateBrimonidine Tartrate17969$2,593
Timolol MaleateTimolol Maleate291,839$1,852
Ketorolac TromethamineKetorolac Tromethamine1033,443$1,670

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$110Genentech USA, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Michael Colin Ryan, M.D.?

Tedicare shows public-source Medicare data for Michael Colin Ryan, M.D. (NPI 1639566003), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael Colin Ryan, M.D. have ACO affiliation data?

Michael Colin Ryan, M.D. is shown with ACO affiliation data for NewYork Quality Care (MSSP, ACO ID A2571) and Rochester Regional Health ACO, Inc. (MSSP, ACO ID A3476).

What billing organization is linked to Michael Colin Ryan, M.D.?

Michael Colin Ryan, M.D. is linked to EYE PHYSICIANS AND SURGEONS OF WESTERN NEW YORK PLLC (billing NPI 1518032333) in the available physician profile data.

Does Michael Colin Ryan, M.D. have Open Payments data?

Michael Colin Ryan, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.